drugset / Trial / NCT06215976

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

NCT06215976 ↗

Phase 4 Recruiting 78 enrolled Cairo University
RandomizedParallel-groupOpen-labelSupportive care

Summary

The goal of this clinical trial is to evaluate the protective effect of metformin on nephrotoxicity of cisplatin in patients with bladder cancer. The main questions it aims to answer are: * To determine protective effect of metformin on structural and functional kidney injury caused by cisplatin in patients with bladder cancer. * To evaluate the safety of combining cisplatin and metformin on patients with bladder cancer

Timeline

Start
2023-06-01
Primary completion
2024-06-01
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg —